LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 108

Search options

  1. Article ; Online: A living donor kidney transplant recipient with mycobacterium senegalense bacteremia: A case report.

    Bugeja, Ann / Hae, Richard / Rajda, Ewa / Clark, Edward G / Akbari, Ayub / Fairhead, Todd / Arianne Buchan, C

    Transplant infectious disease : an official journal of the Transplantation Society

    2021  Volume 23, Issue 4, Page(s) e13596

    Abstract: Mycobacterium senegalense is primarily known in sub-Saharan Africa to cause bovine farcy, a chronic granulomatous inflammation of the skin and lymphatics in cows. Reports of M. senegalense are rare among humans. We report a unique case of M. senegalense ... ...

    Abstract Mycobacterium senegalense is primarily known in sub-Saharan Africa to cause bovine farcy, a chronic granulomatous inflammation of the skin and lymphatics in cows. Reports of M. senegalense are rare among humans. We report a unique case of M. senegalense bloodstream infection in a living donor kidney transplant recipient with multiple possible sources of infection.
    MeSH term(s) Animals ; Bacteremia/diagnosis ; Bacteremia/drug therapy ; Cattle ; Female ; Humans ; Kidney Transplantation/adverse effects ; Living Donors ; Mycobacteriaceae ; Mycobacterium
    Language English
    Publishing date 2021-03-11
    Publishing country Denmark
    Document type Case Reports
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.13596
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination.

    Clark, Richard Todd / Johnson, Lee / Billotti, Jamie / Foulds, Georgia / Ketels, Taryn / Heard, Kennon / Calvello Hynes, Emilie

    Annals of emergency medicine

    2021  Volume 78, Issue 4, Page(s) 511–514

    Abstract: Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin ... ...

    Abstract Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induced thrombotic thrombocytopenia. At this time there have been no reported outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. We describe the early outcomes from the treatment of vaccine-induced thrombotic thrombocytopenia with bivalirudin as a heparin alternative. A 40-year-old Caucasian woman was found to have thrombocytopenia, cerebral venous sinus thrombosis, and pulmonary embolism following vaccination for COVID-19 with Ad26.COV2.S. She exhibited a steady rise in platelet count: 20×10
    MeSH term(s) Ad26COVS1 ; Adult ; Blood Chemical Analysis ; Blood Physiological Phenomena ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Female ; Fibrinolytic Agents/therapeutic use ; Hirudins ; Humans ; Peptide Fragments/therapeutic use ; Pulmonary Embolism/drug therapy ; Pulmonary Embolism/etiology ; Recombinant Proteins/therapeutic use ; Sinus Thrombosis, Intracranial/drug therapy ; Sinus Thrombosis, Intracranial/etiology ; Thrombocytopenia/drug therapy ; Thrombocytopenia/etiology
    Chemical Substances Ad26COVS1 (JT2NS6183B) ; COVID-19 Vaccines ; Fibrinolytic Agents ; Hirudins ; Peptide Fragments ; Recombinant Proteins ; bivalirudin (TN9BEX005G)
    Language English
    Publishing date 2021-07-03
    Publishing country United States
    Document type Case Reports
    ZDB-ID 603080-4
    ISSN 1097-6760 ; 0196-0644
    ISSN (online) 1097-6760
    ISSN 0196-0644
    DOI 10.1016/j.annemergmed.2021.04.035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.

    Boyer, David / Hu, Allen / Warrow, David / Xavier, Samantha / Gonzalez, Victor / Lad, Eleonora / Rosen, Richard B / Do, Diana / Schneiderman, Todd / Ho, Allen / Munk, Marion R / Jaffe, Glenn / Tedford, Stephanie E / Croissant, Cindy L / Walker, Michael / Rückert, Rene / Tedford, Clark E

    Retina (Philadelphia, Pa.)

    2023  Volume 44, Issue 3, Page(s) 487–497

    Abstract: Purpose: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) age-related macular degeneration (AMD) using the LumiThera Valeda Light Delivery System.: Methods: LIGHTSITE III is a randomized, ... ...

    Abstract Purpose: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) age-related macular degeneration (AMD) using the LumiThera Valeda Light Delivery System.
    Methods: LIGHTSITE III is a randomized, controlled trial to assess the safety and effectiveness of PBM in dry AMD. Subjects were given multiwavelength PBM (590, 660, and 850 nm) or Sham treatment delivered in a series of nine sessions over 3 to 5 weeks every four months over 24 months. Subjects were assessed for efficacy and safety outcomes. Data from the 13-month analysis are presented in this report.
    Results: A total of 100 subjects (148 eyes) with dry AMD were randomized. LIGHTSITE III met the primary efficacy best-corrected visual acuity endpoint with a significant difference between PBM (n = 91 eyes) and Sham (n = 54 eyes) groups (Between group difference: 2.4 letters (SE 1.15), CI: -4.7 to -0.1, P = 0.02) (PBM alone: 5.4 letters (SE 0.96), CI: 3.5 to 7.3, P < 0.0001; Sham alone: 3.0 letters (SE 1.13), CI: 0.7-5.2, P < 0.0001). The PBM group showed a significant decrease in new onset geographic atrophy ( P = 0.024, Fisher exact test, odds ratio 9.4). A favorable safety profile was observed.
    Conclusion: LIGHTSITE III provides a prospective, randomized, controlled trial showing improved clinical and anatomical outcomes in intermediate dry AMD following PBM therapy.
    MeSH term(s) Humans ; Low-Level Light Therapy ; Prospective Studies ; Visual Acuity ; Macular Degeneration/diagnosis ; Macular Degeneration/radiotherapy ; Macular Degeneration/drug therapy ; Eye ; Geographic Atrophy/diagnosis ; Geographic Atrophy/radiotherapy
    Language English
    Publishing date 2023-11-14
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 603192-4
    ISSN 1539-2864 ; 0275-004X
    ISSN (online) 1539-2864
    ISSN 0275-004X
    DOI 10.1097/IAE.0000000000003980
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use.

    O'Neal, Hollis R / Sheybani, Roya / Janz, David R / Scoggins, Robert / Jagneaux, Tonya / Walker, James E / Henning, Daniel J / Rosenman, Elizabeth / Mahler, Simon A / Regunath, Hariharan / Sampson, Christopher S / Files, D Clark / Fremont, Richard D / Noto, Michael J / Schneider, Erica E / Shealey, Wesley R / Berlinger, Matthew S / Carver, Thomas C / Walker, Morgan K /
    Ledeboer, Nathan A / Shah, Ajay M / Tse, Henry T K / DiCarlo, Dino / Rice, Todd W / Thomas, Christopher B

    Critical care explorations

    2024  Volume 6, Issue 2, Page(s) e1026

    Abstract: Objectives: To assess the in vitro IntelliSep test, a microfluidic assay that quantifies the state of immune activation by evaluating the biophysical properties of leukocytes, as a rapid diagnostic for sepsis.: Design: Prospective cohort study.: ... ...

    Abstract Objectives: To assess the in vitro IntelliSep test, a microfluidic assay that quantifies the state of immune activation by evaluating the biophysical properties of leukocytes, as a rapid diagnostic for sepsis.
    Design: Prospective cohort study.
    Setting: Five emergency departments (EDs) in Louisiana, Missouri, North Carolina, and Washington.
    Patients: Adult patients presenting to the ED with signs (two of four Systemic Inflammatory Response Syndrome criteria, where one must be temperature or WBC count) or suspicion (provider-ordered culture) of infection.
    Interventions: All patients underwent testing with the IntelliSep using ethylene diamine tetraacetic acid-anticoagulated whole blood followed by retrospective adjudication for sepsis by sepsis-3 criteria by a blinded panel of physicians.
    Measurements and main results: Of 599 patients enrolled, 572 patients were included in the final analysis. The result of the IntelliSep test is reported as the IntelliSep Index (ISI), ranging from 0.1 to 10.0, divided into three interpretation bands for the risk of sepsis: band 1 (low) to band 3 (high). The median turnaround time for ISI results was 7.2 minutes. The ISI resulted band 1 in 252 (44.1%), band 2 in 160 (28.0%), and band 3 in 160 (28.0%). Sepsis occurred in 26.6% (152 of 572 patients). Sepsis prevalence was 11.1% (95% CI, 7.5-15.7%) in band 1, 28.1% (95% CI, 21.3-35.8%) in band 2, and 49.4% (95% CI, 41.4-57.4%) in band 3. The Positive Percent Agreement of band 1 was 81.6% and the Negative Percent Agreement of band 3 was 80.7%, with an area under the receiver operating characteristic curve of 0.74. Compared with band 1, band 3 correlated with adverse clinical outcomes, including mortality, and resource utilization.
    Conclusions: Increasing ISI interpretation band is associated with increasing probability of sepsis in patients presenting to the ED with suspected infection.
    Language English
    Publishing date 2024-02-07
    Publishing country United States
    Document type Journal Article
    ISSN 2639-8028
    ISSN (online) 2639-8028
    DOI 10.1097/CCE.0000000000001026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Risk factors for service use and trends in coverage of different HIV testing and counselling models in northwest Tanzania between 2003 and 2010.

    Cawley, Caoimhe / Wringe, Alison / Todd, Jim / Gourlay, Annabelle / Clark, Benjamin / Masesa, Clemens / Machemba, Richard / Reniers, Georges / Urassa, Mark / Zaba, Basia

    Tropical medicine & international health : TM & IH

    2015  Volume 20, Issue 11, Page(s) 1473–1487

    Abstract: Objectives: To investigate the relative effectiveness of different HIV testing and counselling (HTC) services in improving HIV diagnosis rates and increasing HTC coverage in African settings.: Methods: Patient records from three HTC services [ ... ...

    Abstract Objectives: To investigate the relative effectiveness of different HIV testing and counselling (HTC) services in improving HIV diagnosis rates and increasing HTC coverage in African settings.
    Methods: Patient records from three HTC services [community outreach HTC during cohort study rounds (CO-HTC), walk-in HTC at the local health centre (WI-HTC) and antenatal HIV testing (ANC-HTC)] were linked to records from a community cohort study using a probabilistic record linkage algorithm. Characteristics of linked users of each HTC service were compared to those of cohort participants who did not use the HTC service using logistic regression. Data from three cohort study rounds between 2003 and 2010 were used to assess trends in the proportion of persons testing at different service types.
    Results: The adjusted odds ratios for HTC use among men with increasing numbers of sexual partners in the past year, and among HIV-positive men and women compared to HIV-negative men and women, were higher at WI-HTC than at CO-HTC and ANC-HTC. Among sero-survey participants, the largest numbers of HIV-positive men and women learned their status via CO-HTC. However, we are likely to have underestimated the numbers diagnosed at WI-HTC and ANC-HTC, due to low sensitivity of the probabilistic record linkage algorithm.
    Conclusions: Compared to CO-HTC or ANC-HTC, WI-HTC was most likely to attract HIV-positive men and women, and to attract men with greater numbers of sexual partners. Further research should aim to optimise probabilistic record linkage techniques, and to investigate which types of HTC services most effectively link HIV-positive people to treatment services relative to the total cost per diagnosis made.
    Language English
    Publishing date 2015-08-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1314080-2
    ISSN 1365-3156 ; 1360-2276
    ISSN (online) 1365-3156
    ISSN 1360-2276
    DOI 10.1111/tmi.12578
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.

    Pollack, Charles V / Peacock, W Frank / Bernstein, Richard A / Clark, Carol L / Douketis, James / Fermann, Gregory J / Fiore, Gregory J / Frost, Alex / Jahromi, Babak / Johnson, Charles / Merli, Geno / Silber, Steven / Villines, Todd C / Fanikos, John

    The American journal of emergency medicine

    2019  Volume 38, Issue 6, Page(s) 1163–1170

    Abstract: Objective: The Safety of Oral Anticoagulants Registry (SOAR) was designed to describe the evaluation and management of patients with oral anticoagulant (OAC)-related major bleeding or bleeding concerns who present to the emergency department (ED) with ... ...

    Abstract Objective: The Safety of Oral Anticoagulants Registry (SOAR) was designed to describe the evaluation and management of patients with oral anticoagulant (OAC)-related major bleeding or bleeding concerns who present to the emergency department (ED) with acute illness or injury. Patients in the ED are increasingly taking anticoagulants, which can cause bleeding-related complications as well as impact the acute management of related or unrelated clinical issues that prompt presentation. Modifications of emergency evaluation and management due to anticoagulation have not previously been studied.
    Methods: This was a multicenter observational in-hospital study of patients who were judged to be experiencing an active OAC effect and had (a) an obvious bleeding event or (b) were deemed at risk for serious bleeding spontaneously, after injury, or during an indicated invasive procedure. Diagnostic testing, therapies employed, and clinical outcomes were collected.
    Results: Thirty-one US hospitals contributed data to SOAR. Of 1513 subjects, acute hemorrhage (AH) qualified 78%, while 22% had a bleeding concern (BC). Warfarin was the index OAC in 37.3%, dabigatran in 13.3%, and an anti-Factor X
    Conclusion: Care of anticoagulated patients in the acute care setting is inconsistent, reflecting the diversity of presentation. As the prevalence of OAC use increases with the aging of the US population, further study and targeted educational efforts are needed to drive more evidence-based care of these patients.
    MeSH term(s) Aged ; Aged, 80 and over ; Dabigatran/adverse effects ; Dabigatran/therapeutic use ; Emergency Service, Hospital/organization & administration ; Emergency Service, Hospital/statistics & numerical data ; Factor Xa Inhibitors/adverse effects ; Factor Xa Inhibitors/therapeutic use ; Female ; Gastrointestinal Hemorrhage/epidemiology ; Gastrointestinal Hemorrhage/etiology ; Hemorrhage/epidemiology ; Hemorrhage/etiology ; Humans ; Intracranial Hemorrhages/epidemiology ; Intracranial Hemorrhages/etiology ; Male ; Middle Aged ; Registries/standards ; Registries/statistics & numerical data ; Warfarin/adverse effects ; Warfarin/therapeutic use
    Chemical Substances Factor Xa Inhibitors ; Warfarin (5Q7ZVV76EI) ; Dabigatran (I0VM4M70GC)
    Language English
    Publishing date 2019-12-28
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 605890-5
    ISSN 1532-8171 ; 0735-6757
    ISSN (online) 1532-8171
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2019.12.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Reducing crude protein in beef cattle diet reduces ammonia emissions from artificial feedyard surfaces.

    Todd, Richard W / Cole, N Andy / Clark, R Nolan

    Journal of environmental quality

    2006  Volume 35, Issue 2, Page(s) 404–411

    Abstract: Concentrated animal feeding operations are major sources of ammonia to the atmosphere. Control methods to reduce emissions include acidifying amendments, urease inhibitors, and absorbents. For beef cattle, decreasing crude protein (CP) in diets may be ... ...

    Abstract Concentrated animal feeding operations are major sources of ammonia to the atmosphere. Control methods to reduce emissions include acidifying amendments, urease inhibitors, and absorbents. For beef cattle, decreasing crude protein (CP) in diets may be the most practical and cost-effective method to reduce ammonia emissions. Our objective was to quantify the effect of reducing CP in beef cattle diet on ammonia emissions. Two groups of steers were fed diets with either 11.5 or 13.0% CP and all urine and feces were collected. Manures from the two diet treatments were applied in a replicated laboratory chamber experiment, and ammonia emission was quantified using acid gas washing. In four seasonal field trials, manures from the two diet treatments were applied to two 10-m-diameter, circular, artificial feedyard surfaces, and ammonia emission was quantified using the integrated horizontal flux method. Manure from steers fed 11.5% CP diet had less urine, less urinary N, and a lesser fraction of total N in urine, compared with the 13.0% CP diet. Decreasing crude protein in beef cattle diets from 13 to 11.5% significantly decreased ammonia emission by 44% (p < 0.01) in the closed chamber laboratory experiment, and decreased mean daily ammonia flux by 30% (p = 0.10), 52% (p = 0.08), and 29% (p < 0.01) in summer, autumn, and spring field trials, respectively. No difference was observed in winter. On an annual basis, decreasing crude protein reduced daily ammonia flux by 28%. Reducing crude protein in beef cattle diets may provide the most practical and cost-effective way to reduce ammonia emissions from feedyards.
    MeSH term(s) Air Pollutants/analysis ; Air Pollution/analysis ; Air Pollution/prevention & control ; Ammonia/analysis ; Animal Feed ; Animals ; Cattle ; Diet ; Dietary Proteins ; Manure/analysis ; Nitrogen/analysis ; Nitrogen/urine
    Chemical Substances Air Pollutants ; Dietary Proteins ; Manure ; Ammonia (7664-41-7) ; Nitrogen (N762921K75)
    Language English
    Publishing date 2006-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 120525-0
    ISSN 1537-2537 ; 0047-2425
    ISSN (online) 1537-2537
    ISSN 0047-2425
    DOI 10.2134/jeq2005.0045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Corrigendum to "Priorities to inform research on marine plastic pollution in Southeast Asia" [Sci. Total Environ. volume 841 (2022) Article 156704].

    Omeyer, Lucy C M / Duncan, Emily M / Aiemsomboon, Kornrawee / Beaumont, Nicola / Bureekul, Sujaree / Cao, Bin / Carrasco, Luis R / Chavanich, Suchana / Clark, James R / Cordova, Muhammad R / Couceiro, Fay / Cragg, Simon M / Dickson, Neil / Failler, Pierre / Ferraro, Gianluca / Fletcher, Stephen / Fong, Jenny / Ford, Alex T / Gutierrez, Tony /
    Hamid, Fauziah Shahul / Hiddink, Jan G / Hoa, Pham T / Holland, Sophie I / Jones, Lowenna / Jones, Nia H / Koldewey, Heather / Lauro, Federico M / Lee, Charlotte / Lewis, Matt / Marks, Danny / Matallana-Surget, Sabine / Mayorga-Adame, Claudia G / McGeehan, John / Messer, Lauren F / Michie, Laura / Miller, Michelle A / Mohamad, Zeeda F / Nor, Nur Hazimah Mohamed / Müller, Moritz / Neill, Simon P / Nelms, Sarah E / Onda, Deo Florence L / Ong, Joyce J L / Pariatamby, Agamuthu / Phang, Sui C / Quilliam, Richard / Robins, Peter E / Salta, Maria / Sartimbul, Aida / Shakuto, Shiori / Skov, Martin W / Taboada, Evelyn B / Todd, Peter A / Toh, Tai Chong / Valiyaveettil, Suresh / Viyakarn, Voranop / Wonnapinij, Passorn / Wood, Louisa E / Yong, Clara L X / Godley, Brendan J

    The Science of the total environment

    2022  Volume 857, Issue Pt 3, Page(s) 159595

    Language English
    Publishing date 2022-10-26
    Publishing country Netherlands
    Document type Published Erratum
    ZDB-ID 121506-1
    ISSN 1879-1026 ; 0048-9697
    ISSN (online) 1879-1026
    ISSN 0048-9697
    DOI 10.1016/j.scitotenv.2022.159595
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Uptake of services for prevention of mother-to-child transmission of HIV in a community cohort in rural Tanzania from 2005 to 2012.

    Gourlay, Annabelle / Wringe, Alison / Todd, Jim / Cawley, Caoimhe / Michael, Denna / Machemba, Richard / Clark, Benjamin / Masesa, Clemens / Marston, Milly / Urassa, Mark / Zaba, Basia

    BMC health services research

    2016  Volume 16, Page(s) 4

    Abstract: Background: Estimates of population-level coverage with prevention of mother-to-child transmission (PMTCT) services are vital for monitoring programmes but are rarely undertaken. This study describes uptake of PMTCT services among HIV-positive pregnant ... ...

    Abstract Background: Estimates of population-level coverage with prevention of mother-to-child transmission (PMTCT) services are vital for monitoring programmes but are rarely undertaken. This study describes uptake of PMTCT services among HIV-positive pregnant women in a community cohort in rural Tanzania.
    Methods: Kisesa cohort incorporates demographic and HIV sero-surveillance rounds since 1994. Cohort data were linked retrospectively to records from four Kisesa clinics with PMTCT services from 2009 (HIV care and treatment clinic (CTC) available in one facility from 2008; referrals to city hospitals for PMTCT and antiretroviral treatment (ART) from 2005). The proportion of HIV-positive pregnant women residing in Kisesa in 2005-2012 who accessed PMTCT service components (based on linkage to facility records) was calculated per HIV-positive pregnancy and by year, with adjustments made to account for the sensitivity of the linkage algorithm.
    Results: Out of 1497 HIV-positive pregnancies overall (to 849 women), 26% (n = 387/1497) were not linked to any facility records, 35% (n = 519/1497) registered for ANC but not HIV services (29% (n = 434/1497) were not tested at ANC or diagnosed previously), 8% (n = 119/1497) enrolled in PMTCT but not CTC services (6 % (n = 95/1497) received antiretroviral prophylaxis), and 32% (n = 472/1497) registered for CTC (14% (n = 204/1497) received ART or prophylaxis) (raw estimates). Adjusted estimates for coverage with ANC were 92%, 57% with HIV care, and 29 % with antiretroviral drugs in 2005-2012, trending upwards over time.
    Conclusions: Population-level coverage with PMTCT services was low overall, with weaknesses throughout the service continuum, but increased over time. Option B+ should improve coverage with antiretrovirals for PMTCT through simplified decisions for initiating ART, but will rely on strengthening access to CTC services.
    MeSH term(s) Adult ; Child ; Community Health Services/statistics & numerical data ; Female ; HIV Infections/drug therapy ; HIV Infections/prevention & control ; HIV Infections/transmission ; Health Knowledge, Attitudes, Practice ; Humans ; Infectious Disease Transmission, Vertical/prevention & control ; Patient Acceptance of Health Care/psychology ; Patient Acceptance of Health Care/statistics & numerical data ; Pregnancy ; Pregnant Women/psychology ; Referral and Consultation ; Retrospective Studies ; Rural Population/statistics & numerical data ; Tanzania/epidemiology ; Young Adult
    Language English
    Publishing date 2016-01-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2050434-2
    ISSN 1472-6963 ; 1472-6963
    ISSN (online) 1472-6963
    ISSN 1472-6963
    DOI 10.1186/s12913-015-1249-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.

    Hu, Leland S / D'Angelo, Fulvio / Weiskittel, Taylor M / Caruso, Francesca P / Fortin Ensign, Shannon P / Blomquist, Mylan R / Flick, Matthew J / Wang, Lujia / Sereduk, Christopher P / Meng-Lin, Kevin / De Leon, Gustavo / Nespodzany, Ashley / Urcuyo, Javier C / Gonzales, Ashlyn C / Curtin, Lee / Lewis, Erika M / Singleton, Kyle W / Dondlinger, Timothy / Anil, Aliya /
    Semmineh, Natenael B / Noviello, Teresa / Patel, Reyna A / Wang, Panwen / Wang, Junwen / Eschbacher, Jennifer M / Hawkins-Daarud, Andrea / Jackson, Pamela R / Grunfeld, Itamar S / Elrod, Christian / Mazza, Gina L / McGee, Sam C / Paulson, Lisa / Clark-Swanson, Kamala / Lassiter-Morris, Yvette / Smith, Kris A / Nakaji, Peter / Bendok, Bernard R / Zimmerman, Richard S / Krishna, Chandan / Patra, Devi P / Patel, Naresh P / Lyons, Mark / Neal, Matthew / Donev, Kliment / Mrugala, Maciej M / Porter, Alyx B / Beeman, Scott C / Jensen, Todd R / Schmainda, Kathleen M / Zhou, Yuxiang / Baxter, Leslie C / Plaisier, Christopher L / Li, Jing / Li, Hu / Lasorella, Anna / Quarles, C Chad / Swanson, Kristin R / Ceccarelli, Michele / Iavarone, Antonio / Tran, Nhan L

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 6066

    Abstract: Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular and multi- ... ...

    Abstract Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular and multi-parametric magnetic resonance imaging (MRI) profiling across 313 multi-regional tumor biopsies, including 111 from the NE, across 68 HGG patients. Whole exome and RNA sequencing uncover unique genomic alterations to unresectable invasive NE tumor, including subclonal events, which inform genomic models predictive of geographic evolution. Infiltrative NE tumor is alternatively enriched with tumor cells exhibiting neuronal or glycolytic/plurimetabolic cellular states, two principal transcriptomic pathway-based glioma subtypes, which respectively demonstrate abundant private mutations or enrichment in immune cell signatures. These NE phenotypes are non-invasively identified through normalized K2 imaging signatures, which discern cell size heterogeneity on dynamic susceptibility contrast (DSC)-MRI. NE tumor populations predicted to display increased cellular proliferation by mean diffusivity (MD) MRI metrics are uniquely associated with EGFR amplification and CDKN2A homozygous deletion. The biophysical mapping of infiltrative HGG potentially enables the clinical recognition of tumor subpopulations with aggressive molecular signatures driving tumor progression, thereby informing precision medicine targeting.
    MeSH term(s) Humans ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Brain Neoplasms/pathology ; Multiparametric Magnetic Resonance Imaging ; Homozygote ; Sequence Deletion ; Glioma/diagnostic imaging ; Glioma/genetics ; Glioma/pathology ; Magnetic Resonance Imaging/methods ; Biological Products
    Chemical Substances Biological Products
    Language English
    Publishing date 2023-09-28
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-41559-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top